The U.S. has secured 300 million doses of potential AstraZeneca COVID-19 vaccine. The government will provide up to $1.2 billion to accelerate AstraZeneca’s vaccine development in exchange for access. (Reuters)

CVS Health has expanded drive-thru testing locations to 14 states. The testing will be available at 350 locations. CVS aims to open 1,000 sites nationwide by the end of May. (Reuters)

A quarter of Americans have little or no interest in taking a coronavirus vaccine, according to a poll from Reuters and Ipsos. Many were concerned about the speed at which the vaccine is being developed. (Reuters)

The scientist leading the Trump administration’s vaccine effort has deep ties to pharma. Moncef Slaoui was appointed last week to lead Operation Warp Speed, the federal effort to speed development of a coronavirus vaccine. He previously served on the board of Moderna and was an executive at GlaxoSmithKline. (The New York Times)

A global trial of hydroxychloroquine began, testing the malaria drug’s ability to prevent COVID-19 infections. Healthcare workers in Britain and Thailand are participating in the study, which will include 40,000 healthcare workers across Europe, Africa, Asia and South America. (Reuters)